Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RM-718 by Rhythm Pharmaceuticals for Obesity: Likelihood of Approval
RM-718 is under clinical development by Rhythm Pharmaceuticals and currently in Phase I for Obesity. According to GlobalData, Phase I...